Introduction 59
In the neonatal period, the human kidney displays a tubular immaturity, with associated sodium 60 wasting, negative sodium balance, and impaired water reabsorption (1). This inability to maintain 61 homeostatic function is accentuated in preterm infants (2-4) and represents a critical problem that 62 pediatricians have to deal with. Therefore, a better understanding of water and sodium regulation 63 during this specific developmental period is of major importance in order to propose new therapeutic 64 strategies for the management of preterm infants. 65
Renal sodium reabsorption is mainly controlled by aldosterone, a steroid hormone synthesized in the 66 adrenal gland zona glomerulosa, secondary to renin stimulation via angiotensin II and to potassium 67 stimulation (5). In the distal nephron, aldosterone, by binding to its receptor, the mineralocorticoid 68 receptor (MR), a transcription factor (6), tightly regulates the expression and activity of several 69 transporting proteins implicated in sodium homeostasis, including the alpha subunit of the epithelial 70 sodium channel (ENaC) (7). The selectivity of the mineralocorticoid signaling pathway in the 71 epithelial cells is controlled at a prereceptor level by the 11-hydroxysteroid dehydrogenase type 2 72 enzyme (11HSD2) which metabolizes cortisol (or corticosterone in rodents) into inactive 73 compounds, uncapable of MR binding (8, 9) . We have previously demonstrated that the neonatal 74 sodium wasting is related to a physiological transient renal aldosterone resistance (10). We have also 75 established that this physiological aldosterone resistance is associated in both mice and humans with a 76 low renal MR expression at birth, both at the mRNA and protein level (11). This low renal MR 77 expression in newborns is followed by a significant increase in the postnatal period, with a complete 78 renal tubular expression developed at 8 postnatal days in mice and during the first year of life in 79 humans, paralleling renal maturation. The underlying mechanisms, responsible for the low renal MR 80 expression at birth and its postnatal increase, are currently unknown. Since aldosterone levels are very 81 high at birth and have a tendency to decrease in the postnatal period, mirroring MR expression (11), 82 we hypothesized that these high hormonal levels could contribute to the low neonatal renal MR 83 
Hormonal Analyses 123
Trunk blood was collected into dipotassium-EDTA tubes (Microvette CB K2E, Sarstedt AG & Co), 124 centrifuged at 6,000 rpm for 5 min, and plasma was stored at -80°C until assay. Aldosterone was 125 determined as previously described (14) Charles, MO). Corticosterone was measured using a commercially available radioimmunoassay kit 129 (ImmuChem Double Antibody Corticosterone Kit, MP Biomedicals, Irvine, CA) as described in (14) . 130
131

Organotypic cultures 132
Kidneys were collected from wild type mice on the day of birth (D0) or at postnatal day 8 (D8). Each 133 D0 kidney was incubated for 15 min in 150 µl of accutase (PAA Laboratories, Les Mureaux, France) 134 and D8 kidneys were incubated for 1 h in 300 µl of trypsin (Invitrogen, Cergy-Pontoise, France).
7
Then, kidneys were manually dissected with a needle. Homogenates were pooled and centrifuged for 3 136 min at 300 g, supernatant was withdrawn and cellular pellet was resuspended in a specific epithelial 137 medium described below. Cellular suspensions were then seeded on collagen I-coated 12-well plates 138 (Collagen I from Institut Jacques Boy, France), and routinely cultured for seven days at 37°C in a 139 humidified incubator gassed with 5% CO2 within an epithelial medium composed of DMEM/HAM's 140 F12 (1:1), 2 mM glutamine, 50 nM dexamethasone, 50 nM sodium selenite, 5 µg/ml transferrin, 5 141 µg/ml insulin, 10 ng/ml EGF, 2 nM T3, 100 U/ml penicillin/streptomycin, 20 mM HEPES, pH 7.4, 5% 142 dextran charcoal-treated serum and 1% amphotericin B (the latter added to the medium for the first 143
h of culture only). 144
To investigate aldosterone and corticosteroid action, the epithelial medium was replaced at day 7 of 145 culture by a minimal medium (MM), which has the same composition as the epithelial medium but 146 lacks dexamethasone and dextran charcoal-treated serum. After 24 h in MM, either ethanol or 147 aldosterone or dexamethasone, as well as spironolactone, were added to the medium for 24 h as 148
indicated. 149 150
RT-PCR and Quantitative real-time PCR 151
Total RNA was extracted from tissues or cells with the TRIZOL reagent (Invitrogen) according to the 152 manufacturer's recommendations, and RNA was thereafter processed for RT-PCR, as previously 153 described (11). One μg of total RNA, isolated from frozen samples, was subjected to DNase I 154 Amplification Grade treatment (Invitrogen) and then reverse-transcribed by use of High-Capacity 155 cDNA RT kit from Applied Biosystems (Courtaboeuf, France). Samples were diluted 10-fold then 156 1/20 of the reverse transcription reaction was used for qRT-PCR using the Fast SYBR ® Green Master 157 Mix (ABI, Applied Biosystems) containing 300 nM of specific primers (supplemental Table) . qPCR 158 was carried out on a StepOnePlus™ Real-Time PCR System (Applied Biosystems, Foster City, CA). 159
Reaction parameters were as follows: 95°C for 20 s, then 40 cycles at 95°C for 1 s and 60°C for 20 s. 160
For standards preparation, amplicons were purified from agarose gel and subcloned into pGEMT-easy 161 plasmid (Promega, Charbonnières-les-Bains, France) and sequenced to confirm the identity of each 162 sequence. Standard curves were generated using serial dilutions of linearized standard plasmids, 163 8 spanning 6 orders of magnitude. Standard and sample values were amplified in duplicate and analyzed 164 from three independent experiments. Ribosomal 18S was used as an internal control for data 165 normalization. Relative expression of a given gene is expressed as the ratio attomoles of specific 166 gene/femtomoles of 18S. Results are mean ± SEM and represent the relative expression compared 167 with that obtained in AS -/ -mice kidneys at D0, which was arbitrarily set at 1. Supplemental Table  168 indicates primer sequences of genes analyzed by qRT-PCR. 169
170
Immunocytochemistry 171
Cells were fixed in 10% buffered-formol in PBS (pH 7.3) for 15 min and then washed 3 times in PBS 172 before processing for immunocytochemistry, as previously described (11). For immunocytochemical 173 analyses, we used the monoclonal anti-MR antibody clone 6G1, generously provided by Dr Gomez-174
Sanchez (University of Mississippi, USA) (15), at the dilution of 1:40. 175
176
Statistical analyses 177
Results are expressed as mean ± SEM of at least three independent analyses with at least 6 samples for 178 each developmental stage. Statistical analyses were performed using a non parametric Mann Whitney 179 test (Prism4, Graphpad Software, Inc., San Diego, CA), with significant threshold at 0.05. 180 181 182
Results
183
Breeding strategy 184
We conducted a specific breeding strategy in order to obtain four different newborn mice with various 185 genotypes and distinct developmental endocrine patterns. We obtained AS -/ -pups that had never been 186 animals at D0 and D8 (Fig 2) . No difference was evident at birth between genotypes, therefore 208 suggesting that the low renal MR expression during the neonatal period is independent of aldosterone 209 exposure. In all conditions, a significant increase in renal MR mRNA expression level was observed in 210 all animals at D8, demonstrating that aldosterone does not intervene into the postnatal upregulation of 211 renal MR expression. However, we found a significant difference (p<0. We have previously demonstrated in WT mice (11), a parallel evolution throughout renal development 217 between MR, and both the 11HSD2 enzyme, which confers mineralocorticoid selectivity, and 218 ENaC, a prototypal MR target gene. Since corticosterone levels were very high in AS -/ -mice, we 219 wondered whether the expression profiles of 11HSD2 and ENaC would be modified in the four 220 different genotypes. It has indeed been suggested that the glucocorticoid pathway could be implicated 221 in the regulation of these two genes (17-19). The question raised was whether corticosterone could 222 compensate for aldosterone deficiency in AS -/ -mice by inducing ENaC expression via binding to the 223 glucocorticoid receptor (GR). The latter is a transcription factor closely related to MR and also known 224 to activate gene expression implicated in sodium transport (18, 19). 11HSD2 and ENaC mRNA 225 expression were therefore analyzed at D0 and D8 in all genotypes. 11HSD2 displayed an identical 226 expression profile to that of the MR, with a low expression at birth and a significant increase in the 227 postnatal period, independent of aldosterone status (Fig 3A) . On the contrary, ENaC mRNA 228 expression profile appeared strikingly different (Fig 3B) . Indeed, ENaC mRNA levels were very low 229 in AS -/ -mice both at D0 and D8, with no significant postnatal increase. ENaC expression evolved in 230 parallel with aldosterone levels, with a 1.5-fold and a 2-fold increase at birth in AS + / -and WT mice, 231 respectively, and a 2.5-fold and 3-fold induction at D8 in these same genotypes, compared to levels in 232 and their substantial levels of GR expression (see Supplemental Figure) , glucocorticoid signaling 243 cannot functionally compensate the lack of mineralocorticoid signaling. 244
AS
245
Organotypic cultures 246
We next decided to establish a reliable cell-based model to further investigate the hormonal regulatory 247 mechanisms of renal MR expression in the neonatal period. We thus chose to grow organotypic 248 
Impact of Aldosterone on gene expression in organotypic cultures 264
To explore the impact of mineralocorticoid and glucocorticoid hormones on neonatal renal mRNA 265 expression, we incubated organotypic cultures of wild type D0 and D8 mouse kidneys with various 266 steroids (aldosterone or dexamethasone). No variation in MR mRNA levels was observed in OCD0 267 after 24 h treatment with either hormone (Fig 4C) , providing additional support for the lack of 268 corticosteroid hormone effects on MR expression when comparing D0 AS -/ -and WT mice (see Fig 2) . 269
However, our cell model was sensitive to glucocorticoid but not aldosterone action since 270 dexamethasone, a steroid compound that is not submitted to metabolic conversion by the 11HSD2 271 enzyme (20), was able to induce ENaC expression (data not shown), most likely through 272 glucocorticoid receptor activation. Indeed, the absence of MR protein in OCD0 explains why 273 aldosterone is inefficient in inducing ENaC expression. Finally, in sharp contrast, in OCD8 cultures, 274
clearly expressing MR protein, aldosterone, but not dexamethasone, was able to induce a significant 2-275 fold increase of MR transcripts (p < 0.01) (Fig 4C) . This result corroborates the in vivo findings 276 The low yet detectable ENaC mRNA levels measured at birth in AS-/-mice, in the absence of 296 aldosterone and concomitant with a very low MR expression, emphasize the redundancy of gene 297 expression regulation. Indeed, the mineralocorticoid pathway is not the sole regulator of ENaC 298 expression. It can also be controlled by other transcription factors, such as the GR (21). We have 299 previously demonstrated that GR is expressed in the neonatal kidney both at the mRNA and protein 300 levels, and is detected in the nuclei of the cortical collecting duct cells, consistent with a functional 301 GR-mediated signaling pathway (11). GR is also detected in the kidney of AS -/ -newborns. Therefore 302 the glucocorticoid signaling pathway could account for these detectable ENaC mRNA levels at birth. 303
However, in comparison, the abundance of ENaC mRNA presented a strict positive relationship with 304 aldosterone status, with a significant increase in ENaC mRNA levels in AS heterozygous and WT 305 newborns as compared to AS -/ -mice at D0, associated with a further increase at D8, as previously 306 
